Sharda Pharmaceuticals Retail And Distri Bution Llp
Pharmaceutical retail and distribution company specializing in medicine and bulk drugs.
2020 | Mumbai, Maharashtra (India) | Active
Sharda Pharmaceuticals Retail And Distri Bution Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Sharda Pharmaceuticals Retail And Distri Bution Llp
Sharda Pharmaceuticals Retail And Distri Bution Llp (SPRADBL) is 4 Year, 7 Months old Limited Liability Partnership 19 July 2020. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAS-9609
- Incorporation Date
19 Jul 2020
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Pharma
Who are the key members and board of directors at Sharda Pharmaceuticals Retail And Distri Bution Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeetendra Gupta  | Designated Partner | 19-Jul-2020 | Current |
| Savita Gupta | Designated Partner | 19-Jul-2020 | Current |
| Sarita Gupta | Designated Partner | 19-Jul-2020 | Current |
Financial Performance of Sharda Pharmaceuticals Retail And Distri Bution Llp.
Enhance accessibility to Sharda Pharmaceuticals Retail And Distri Bution Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sharda Pharmaceuticals Retail And Distri Bution Llp?
Unlock access to Sharda Pharmaceuticals Retail And Distri Bution Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- 2Snm Consultancy Services Llp
Sarita Gupta is a mutual person
- Ashre Diligent Advisors Private Limited
Sarita Gupta is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Sharda Pharmaceuticals Retail And Distri Bution Llp?
Unlock and access historical data on people associated with Sharda Pharmaceuticals Retail And Distri Bution Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sharda Pharmaceuticals Retail And Distri Bution Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharda Pharmaceuticals Retail And Distri Bution Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.